Trial
NCT05275868
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Non-small Cell Lung Cancer
Intervention
MGY825
Why stopped
The trial was terminated due to a business decision and not as a result of any safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-10